Cargando…
Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches
Medulloblastoma (MB) is the most common malignant childhood tumor of the brain. Multimodal treatment consisting of surgery, radiation therapy, and chemotherapy reduced cumulative incidence of late mortality but increased the incidence of subsequent neoplasms and severe, incapacitating chronic health...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098941/ https://www.ncbi.nlm.nih.gov/pubmed/31970590 http://dx.doi.org/10.1007/s10555-020-09854-1 |